Jayari, Raihana S.

HRN: 26-95-42  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/13/2025
CEFTRIAXONE 1G (VIAL)
04/13/2025
04/20/2025
IV
430mg
OD
PCAP
Waiting Final Action 
04/13/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/13/2025
04/20/2025
IV
65mg
OD
PCAP
Waiting Final Action 
04/20/2025
CEFTRIAXONE 1G (VIAL)
04/20/2025
04/26/2025
IV
430
Q24
CNS INFECTION
Waiting Final Action 
04/20/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/20/2025
04/26/2025
IV DRIP
65
Q24
ASPIRATION PNEUMONIA
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: